Gynaecosid Methyloestrenolone 5.0 mg, Methyloestradiol 0.3 mg

Indication

Gynaecosid contains a synthetic progestogen (Methyloestrenolone) and a synthetic oestrogen (Methyloestradiol). It has been used traditionally for the management of primary and secondary amenorrhoea (absent or delayed menstruation). Note: The safety and current regulatory approval status of this combination should be verified, as it may not be approved in all countries.

Ingredients

• Methyloestrenolone 5.0 mg
• Methyloestradiol 0.3 mg

Direction

Adults: Typically one tablet orally per day for a short course as directed by a physician. Exact dosage and duration must be prescribed by a qualified healthcare provider.

Side effects

• Possible: nausea
• vomiting
• abdominal discomfort.
• Possible: menstrual irregularities.
• Possible: headache
• breast tenderness.
• Serious: increased risk of thromboembolic events.
• Serious: possible teratogenic effects if inadvertently used in early pregnancy.

Precautions

• Contraindicated in pregnancy — may cause foetal harm.
• Contraindicated in breast cancer
• oestrogen
• dependent tumours
• or genital malignancies.
• Contraindicated in undiagnosed vaginal bleeding.
• Contraindicated in severe hepatic impairment.
• Contraindicated in history of thromboembolic disorders.
• Use only under strict medical supervision.
• Consult a physician before use.